Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells

被引:75
作者
Distler, JHW
Jüngel, A
Caretto, D
Schulze-Horsel, U
Kowal-Bielecka, O
Gay, RE
Michel, BA
Müller-Ladner, U
Kalden, JR
Gay, S
Distler, O [1 ]
机构
[1] Univ Zurich Hosp, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland
[2] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
[3] Med Univ Bialystok, Bialystok, Poland
[4] Univ Giessen, D-35390 Giessen, Germany
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 01期
关键词
D O I
10.1002/art.21497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Monocyte chemoattractant protein I (MCP-1; CCL2) has been implicated-in the pathogenesis of fibrotic diseases and is up-regulated in patients with systemic sclerosis (SSc). The aim of the present study was to examine the mechanisms by which MCP-1 mediates its profibrotic effects in the setting of SSc. Methods. The expression of receptors for MCP-1 on dermal fibroblasts was analyzed by real-time polymerase chain reaction and fluorescence-activated cell sorting. The ability of extracellular matrix proteins to bind and release MCP-1 was quantified by enzyme-linked immunosorbent assay. Th0 cells were isolated using a magnetic-activated cell sorting system and were stimulated twice in the presence of MCP-1. The synthesis of collagen was measured using the Sircol collagen assay kit. Results. The glycosaminoglycan chondroitin sulfate, but not fibronectin or collagens, bound and released MCP-1 in a time-dependent manner. MCP-1 that was released from chondroitin sulfate induced the differentiation of interleukin-4 (IL-4)-producing T cells in a dose-dependent manner. In turn, dermal fibroblasts from patients with SSc expressed IL-4 receptor, and stimulation with IL-4 significantly increased the production of collagen in dermal fibroblasts. In contrast, CCR2a and CCR2b, as well as D6 and US28 (other potential receptors of MCP-1), were not detectable in SSc and normal fibroblasts, and their expression was not induced by platelet-derived growth factor, IL-1 beta, or IL-4. In addition, MCP-1 had no direct effects on collagen production by fibroblasts. Conclusion. MCP-1 has no direct effects on dermal fibroblasts but contributes to fibrosis in patients with SSc by inducing the differentiation of IL-4-producing T cells. Because MCP-1 has both proinflammatory and profibrotic effects, pharmacologic targeting of MCP-1 could be a promising therapeutic approach in SSc.
引用
收藏
页码:214 / 225
页数:12
相关论文
共 50 条
[31]   Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1 -: Implications for structure and function in vivo [J].
Lau, EK ;
Paavola, CD ;
Johnson, Z ;
Gaudry, JP ;
Geretti, E ;
Borlat, F ;
Kungl, AJ ;
Proudfoot, AE ;
Handel, TM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :22294-22305
[32]  
LEROY EC, 1988, J RHEUMATOL, V15, P202
[33]   RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis [J].
Lloyd, GM ;
Minto, AW ;
Dorf, ME ;
Proudfoot, A ;
Wells, TNC ;
Salant, DJ ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (07) :1371-1380
[34]   Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells [J].
Lunardi, C ;
Bason, C ;
Navone, R ;
Millo, E ;
Damonte, G ;
Corrocher, R ;
Puccetti, A .
NATURE MEDICINE, 2000, 6 (10) :1183-1186
[35]   Chemokines - Chemotactic cytokines that mediate inflammation [J].
Luster, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :436-445
[36]  
Mavilia C, 1997, AM J PATHOL, V151, P1751
[37]   Leukocyte extravasation: chemokine transport and presentation by the endothelium [J].
Middleton, J ;
Patterson, AM ;
Gardner, L ;
Schmutz, C ;
Ashton, BA .
BLOOD, 2002, 100 (12) :3853-3860
[38]  
MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
[39]  
MILLER EJ, 1982, METHOD ENZYMOL, V82, P3
[40]   The amino-terminal extracellular domain of the MCP-1 receptor, but not the RANTES/MIP-1 alpha receptor, confers chemokine selectivity - Evidence for a two-step mechanism for MCP-1 receptor activation [J].
Monteclaro, FS ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19084-19092